NeOnc gets UAE clearance for NEO212 brain tumor drug trial
NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) announced that the Department of Health – Abu Dhabi has granted Investigational New Drug ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
